Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.
about
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1Molecular strategies to inhibit HIV-1 replicationGeneration and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells.Live attenuated AIDS viruses as vaccines: promise or peril?Replication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replicationInhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.A candidate live inactivatable attenuated vaccine for AIDS.Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strainsInversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs.Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine.Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development.Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA.A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly
P2860
Q24673389-464B8F30-079E-4235-B9D2-0AFCDA2FAF29Q24799813-7466957A-0C5C-498E-9E12-4F276502D868Q31106756-9BC8A0E3-29AE-4DD1-8E2A-BF1314EAEF85Q33635315-5229EDB3-A332-4E1B-8793-F1EEA032BCC6Q33776149-15F45ED1-B270-4B6B-8977-D3328077BFE9Q35666657-2B237447-F389-41F2-8EEB-FBA13ACAB9FCQ36898892-8DC69B0A-C3AC-4C4A-87DD-C43B039C7099Q37364176-FBD8DB0B-B7CD-4EF2-AB5C-75A70D67478AQ39549272-F2E49FA3-4360-41C5-9C76-790A3761CAB6Q39976644-E4FA18F6-2DDE-4C29-B9A3-E1BD85EB7DAEQ40800305-9126578D-6B64-42A5-8163-5624938B1A19Q40949172-E31AAC4E-ABE6-45B2-8C83-D70DD7DB0BA2Q41175211-78D9DAEC-22BD-4686-B905-1B7DBC443763Q42126893-E3ED33CC-7C96-4B13-86D1-1226B866E212
P2860
Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Conditional reduction of human ...... s 1 thymidine kinase function.
@ast
Conditional reduction of human ...... s 1 thymidine kinase function.
@en
type
label
Conditional reduction of human ...... s 1 thymidine kinase function.
@ast
Conditional reduction of human ...... s 1 thymidine kinase function.
@en
prefLabel
Conditional reduction of human ...... s 1 thymidine kinase function.
@ast
Conditional reduction of human ...... s 1 thymidine kinase function.
@en
P2093
P2860
P356
P1476
Conditional reduction of human ...... s 1 thymidine kinase function.
@en
P2093
P2860
P304
P356
10.1073/PNAS.93.15.7955
P407
P577
1996-07-01T00:00:00Z